Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kohler

Showing results (31-40 of 238) with videos related to

Pageof 24
Sort By:
Blood|December 18, 2002
Factor XIII activation by thrombin depends on FXIIIVal34Leu genotypeVerena Schroeder, Hans P Kohler
Praxis|February 24, 2001
[What is your diagnosis? Lung metastases of hypopharyngeal carcinoma]A Muller, H P Kohler
Therapeutische Umschau. Revue Therapeutique|July 8, 2005
[Acute chest pain--it's not always the heart! What additional laboratory and diagnostic imaging is needed]H P Kohler, F Nohl
Praxis|February 13, 1996
[Jaundice, anemia and mitral valve insufficiency following mitral valve reconstruction]H P Kohler, R Streuli
Seminars in Thrombosis and Hemostasis|August 10, 2013
Factor XIII deficiency: an updateVerena Schroeder, Hans P Kohler
Applied and Environmental Microbiology|December 1, 1994
Pseudomonas sp. strain HBP1 Prp degrades 2-isopropylphenol (ortho-cumenol) via meta cleavageF Reichlin, H P Kohler
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
The role of factor XIIIVal34Leu in cardiovascular diseaseH P Kohler, P J Grant
Thrombosis and Haemostasis|December 8, 1998
Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarctionH P Kohler, P J Grant
The New England Journal of Medicine|June 15, 2000
Plasminogen-activator inhibitor type 1 and coronary artery diseaseH P Kohler, P J Grant
Archives of Gynecology|December 29, 1978
[Comparative high rising dose study of oral 17-alpha-ethinylestradiol (EE2), estriol (E3), and parenteral 16-alpha-17-beta-estrioldihemisuccinate (E3-suc) in their effects on serum levels of glutamate transaminase (GOT), pyruvate transaminase (GPT), leucine amino peptidase (LAP), alkaline phosphatase (AP), and bilirubin in 30 hysterectomized and ovarectomized women (author's transl)]D Leis, H Zach, P Kohler
Pageof 24

Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
Blood|December 18, 2002
Factor XIII activation by thrombin depends on FXIIIVal34Leu genotypeVerena Schroeder, Hans P Kohler
Praxis|February 24, 2001
[What is your diagnosis? Lung metastases of hypopharyngeal carcinoma]A Muller, H P Kohler
Therapeutische Umschau. Revue Therapeutique|July 8, 2005
[Acute chest pain--it's not always the heart! What additional laboratory and diagnostic imaging is needed]H P Kohler, F Nohl
Praxis|February 13, 1996
[Jaundice, anemia and mitral valve insufficiency following mitral valve reconstruction]H P Kohler, R Streuli
Seminars in Thrombosis and Hemostasis|August 10, 2013
Factor XIII deficiency: an updateVerena Schroeder, Hans P Kohler
Applied and Environmental Microbiology|December 1, 1994
Pseudomonas sp. strain HBP1 Prp degrades 2-isopropylphenol (ortho-cumenol) via meta cleavageF Reichlin, H P Kohler
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
The role of factor XIIIVal34Leu in cardiovascular diseaseH P Kohler, P J Grant
Thrombosis and Haemostasis|December 8, 1998
Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarctionH P Kohler, P J Grant
The New England Journal of Medicine|June 15, 2000
Plasminogen-activator inhibitor type 1 and coronary artery diseaseH P Kohler, P J Grant
Archives of Gynecology|December 29, 1978
[Comparative high rising dose study of oral 17-alpha-ethinylestradiol (EE2), estriol (E3), and parenteral 16-alpha-17-beta-estrioldihemisuccinate (E3-suc) in their effects on serum levels of glutamate transaminase (GOT), pyruvate transaminase (GPT), leucine amino peptidase (LAP), alkaline phosphatase (AP), and bilirubin in 30 hysterectomized and ovarectomized women (author's transl)]D Leis, H Zach, P Kohler
Pageof 24